Stock Watch: Reclassified Revenues Help Novartis's Fourth Quarter
Last-Minute Revenue Reclassifications Are Probably Not Reproducible
A one-off revenue rabbit brought out of the hat may have helped Novartis's fourth-quarter sales but its analysts and investors were not impressed.
